Randomized , double-blind , placebo-controlled study ; males @ years with nm-dystrophinopathy received study drug orally @ times daily , ataluren @ , @ , @ mg/kg ( N = @ ) ; ataluren @ , @ , @ mg/kg ( N = @ ) ; or placebo ( N = @ ) for @ weeks .